Science

Diagnosing Dx

by Elevra Consulting

Life SciencesScience

Is this your show? Claim it

Listen on Apple Podcasts RSS feed

Recently ranked · United States

Last recorded placements from this show’s chart history. These are not current rankings.

Not on the United States charts we track today.

If you like Diagnosing Dx, try…

Cancer Connections

Also in Life Sciences

Talking Transfusion: The Transfusion Evidence Round-Up Podcast

Also in Life Sciences

Paléoanthropologie du genre Homo - Jean-Jacques Hublin

Also in Life Sciences

EHA Unplugged

Also in Life Sciences

Clinical Pharmacology Podcast with Nathan Teuscher

Also in Life Sciences

The Chain: Protein Engineering Podcast

Also in Life Sciences

Latest episodes

Can AI Help Us Treat Cancer Without Overtreating Patients? Oliver Bathe, Qualisure Diagnostics

October 27, 2026 · 33 min

In this episode of Diagnosing Dx, David Filby is joined by Dr Oliver Bathe, Founder and CEO of Qualisure Diagnostics. After more than 25 years as a surgical oncologist, Oliver moved into diagnostics with a goal of helping clinicians make…
Could Genomic Testing Be as Accessible as a Smartphone? Ana Cornell, CEO & Founder of Acorn Genetics

October 21, 2026 · 39 min

In this episode of Diagnosing Dx, David Filby is joined by Ana Cornell, Founder and CEO of Acorn Genetics. Ana started Acorn after experiencing first-hand how expensive and inaccessible genomic testing could be. While studying biomedical…
Could High Frequency Monitoring Transform Autoimmune Care? Kavya Swaminathan

October 14, 2026 · 43 min

In this episode of Diagnosing Dx, David Filby is joined by Kavya Swaminathan, PhD, Co-Founder and CEO of Kascaid. An immunologist and proteomics scientist by training, Kavya has spent her career studying immune dysregulation and biomarker…
Could a 10-Minute Test Stop Unnecessary Antibiotic Prescribing? Paul Kase, CCO - Lumos Diagnostics

October 7, 2026 · 37 min

In this episode of Diagnosing Dx, David Filby is joined by Paul Kase, Chief Commercial Officer at Lumos Diagnostics. Paul brings 30 years of healthcare experience, including more than 20 years in rapid point-of-care diagnostics. His…
Will Payer-Dependent Diagnostics Companies Get Left Behind? Marty Keiser, Founder at IVBH / Mammogen

September 29, 2026 · 35 min

In this episode of Diagnosing Dx, David Filby is joined by Marty Keiser, Founder and CEO of IVBH. After beginning his career in asset management and capital markets, Marty moved into biotech eight years ago with a focus on blood-based…

Show 7 more episodesShow fewer episodes

What If the Patients Who Need Your Test Are Already Hiding in the EHR? Sagacity Diagnostics

September 23, 2026 · 38 min

In this episode of Diagnosing Dx, David Filby is joined by Raymond Tarr, Founder of Sagacity Diagnostics. Raymond brings more than 25 years of experience across diagnostics, rare disease, commercialisation and patient finding, with…
Can Strategic Partnerships Save Diagnostics Innovation? Robert Carlson

September 15, 2026 · 43 min

In this episode of Diagnosing Dx, David Filby is joined by Robert Carlson, Founder and President of Life Science Dx Consulting. Robert brings 30 years of experience across diagnostics and life sciences, spanning scientific, commercial…
Could More Frequent Blood Testing Transform How We Detect Disease?

September 9, 2026 · 40 min

In this episode of Diagnosing Dx, David Filby is joined by Octavian Florescu, CEO of In Diagnostics. An electrical engineer and microchip designer by training, Octavian has spent his career exploring how semiconductor technology can be…
Why Are Vector-Borne Infections Still So Difficult to Diagnose?

September 2, 2026 · 36 min

In this episode of Diagnosing Dx, David Filby is joined by Nicole Bell, CEO of Galaxy Diagnostics. Nicole’s route into vector-borne disease diagnostics is deeply personal. After her husband was initially diagnosed with early-onset…
What Can Diagnostics Founders Learn From Two Successful Exits? Andrew Miller

August 26, 2026 · 36 min

In this episode of Diagnosing Dx, David Filby is joined by Andrew Miller, a diagnostics founder, advisor and two-time exited CEO. A scientist by training, Andrew founded and led companies focused on rapid molecular diagnostics, taking…
98% of Cancer Patients Outside the US Miss Genomic Testing. Can AI Change That?

August 18, 2026 · 39 min

In this episode of Diagnosing Dx, David Filby is joined by Travis Wold, Chief Executive Officer at Imagenomix. Travis brings experience across cancer diagnostics, genomics, liquid biopsy, and international commercialization. We explore…
Could 20-Minute Hormone Testing Transform Patient Care? Nedal Safwat, SVP at Canatu

August 11, 2026 · 46 min

In this episode of Diagnosing Dx, David Filby is joined by Nedal Safwat, Senior Vice President of Medical Diagnostics at Canatu and President of Canatu Inc. With more than 20 years in diagnostics, Nedal has held leadership roles across…

Full episode archive on Apple Podcasts →

About the show

How do we transform cutting-edge scientific discoveries into life-saving diagnostics? On Diagnosing Dx, we explore the scientific innovation driving diagnostics forward, unpack industry challenges, and spotlight success stories. Join us as we speak with leading researchers and innovators at the forefront of Dx. Learn to: 🔹 Navigate industry challenges 🔹 Understand emerging science 🔹 Strategise for growth 🔹 Gain future-focused insight Essential listening for everyone involved in bringing new sciences to life in the Dx and Omics industry, Subscribe now!